<DOC>
	<DOCNO>NCT01967069</DOCNO>
	<brief_summary>The objective study compare efficacy safety DFD01 Spray Vehicle Spray topical treatment moderate plaque psoriasis</brief_summary>
	<brief_title>A Comparison DFD01 Spray Versus Vehicle Spray Subjects With Moderate Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Subjects must present clinical diagnosis stable ( least 3 month ) plaquetype psoriasis . Subjects psoriasis involve 10 20 % BSA , include face , scalp , groin , axillae intertriginous area . Subjects must IGA grade 3 ( moderate ) Baseline Visit Current diagnosis unstable form psoriasis include guttate , erythrodermic , exfoliative pustular psoriasis Other inflammatory skin disease may confound evaluation plaque psoriasis ( e.g. , atopic dermatitis , contact dermatitis , tinea corporis ) . Presence pigmentation , extensive scarring , pigment lesion sunburn could interfere rating efficacy parameter . History psoriasis unresponsive topical treatment . History organ transplant require immunosuppression , HIV , immunocompromised state . Use within 180 day prior Baseline Visit biologic treatment psoriasis ( e.g. , infliximab , adalimumab , etanercept , ustekinumab , alefacept ) . Have receive treatment type cancer within 5 year Baseline Visit except skin cancer cervical cancer ( situ ) allow within 1 year Baseline Visit . Use within 60 day prior Baseline Visit : 1 ) immunosuppressive drug ( e.g. , tacrolimus , pimecrolimus ) , 2 ) systemic antipsoriatic treatment ( e.g. , methotrexate , cyclosporine , hydroxyurea ) 3 ) oral retinoids ( e.g. , acitretin , isotretinoin ) . Use within 30 day prior Baseline Visit : 1 ) systemic steroid , 2 ) PUVA therapy , 3 ) systemic antiinflammatory agent ( e.g. , mycophenolate mofetil , sulfasalazine , 6thioguanine ) , 4 ) UVB therapy . Inhaled , intraocular , intranasal steroid allow . Use within 14 day prior Baseline Visit : 1 ) topical antipsoriatic drug ( e.g. , salicylic acid , anthralin , coal tar , calcipotriene ) , 2 ) topical retinoids ( e.g. , tazarotene , tretinoin ) 3 ) topical corticosteroid . Require use beta blocker , lithium , ACE inhibitor , and/or NSAIDs ( indomethacin , ibuprofen , aspirin , naproxen ) medical history medication affect subject 's psoriasis , except subject use medication routinely 180 day prior Baseline Visit , medication allow .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>